======= C2CD5 ======= == Gene Information == * **Official Symbol**: C2CD5 * **Official Name**: C2 calcium dependent domain containing 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9847|9847]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q86YS7|Q86YS7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=C2CD5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C2CD5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/618044|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |C2| |insulin receptor signaling pathway via phosphatidylinositol 3-kinase| |positive regulation of vesicle fusion| |positive regulation of protein targeting to membrane| |regulation of vesicle fusion| |regulation of protein targeting to membrane| |positive regulation of glucose import| |positive regulation of glucose transmembrane transport| |intracellular protein transmembrane transport| |regulation of glucose import| |calcium-dependent phospholipid binding| |protein transmembrane transport| |vesicle fusion| |regulation of glucose transmembrane transport| |organelle membrane fusion| |regulation of protein targeting| |insulin receptor signaling pathway| |ruffle membrane| |organelle fusion| |positive regulation of protein localization to membrane| |membrane fusion| |cell cortex| |cytoplasmic vesicle membrane| |positive regulation of intracellular protein transport| |microtubule organizing center| |cellular response to insulin stimulus| |protein localization to plasma membrane| |regulation of protein localization to membrane| |positive regulation of transmembrane transport| |positive regulation of intracellular transport| |response to insulin| |protein localization to cell periphery| |regulation of intracellular protein transport| |cellular response to peptide hormone stimulus| |vesicle organization| |positive regulation of cellular protein localization| |cellular response to peptide| |regulation of intracellular transport| |response to peptide hormone| |positive regulation of protein transport| |positive regulation of establishment of protein localization| |response to peptide| |protein localization to membrane| |transmembrane receptor protein tyrosine kinase signaling pathway| |regulation of cellular protein localization| |regulation of vesicle-mediated transport| |regulation of transmembrane transport| |cellular response to organonitrogen compound| |cellular response to hormone stimulus| |positive regulation of organelle organization| |cellular response to nitrogen compound| |regulation of protein transport| |enzyme linked receptor protein signaling pathway| |calcium ion binding| |regulation of peptide transport| |regulation of establishment of protein localization| |membrane organization| |response to hormone| |regulation of cellular localization| |positive regulation of transport| |intracellular protein transport| |response to organonitrogen compound| |regulation of protein localization| |cellular response to oxygen-containing compound| |response to nitrogen compound| |positive regulation of cellular component organization| |cellular response to endogenous stimulus| |transmembrane transport| |regulation of organelle organization| |response to endogenous stimulus| |protein transport| |intracellular transport| |peptide transport| |response to oxygen-containing compound| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |establishment of localization in cell| |nitrogen compound transport| |regulation of transport| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|-2.14| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-1.99| |[[:results:exp393|Resminostat 0.5μM R07 exp393]]|-1.98| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|-1.95| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-1.92| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-1.87| |[[:results:exp421|VHL-ligand-1 20μM R07 exp421]]|-1.86| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|-1.75| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|-1.74| |[[:results:exp19|Etoposide 1μM R00 exp19]]|1.74| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|1.8| |[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|1.86| |[[:results:exp70|INK128 0.2μM R02 exp70]]|1.89| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|1.9| |[[:results:exp15|Cycloheximide 0.2μM R00 exp15]]|1.98| |[[:results:exp20|Etoposide 10μM R00 exp20]]|2.02| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|2.08| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|2.16| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|2.21| |[[:results:exp90|WYE-354 6μM R02 exp90]]|2.41| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|2.77| |[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|4.46| ^Gene^Correlation^ |[[:human genes:f:fibp|FIBP]]|0.615| |[[:human genes:k:kiaa0195|KIAA0195]]|0.449| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10177 * **Expression level (log2 read counts)**: 6.3 {{:chemogenomics:nalm6 dist.png?nolink |}}